• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mucosal immunization in perspective

tetano

Editor, Senior Moderator
Hum Vaccin Immunother. 2014 Jul;10(7):2115-7. doi: 10.4161/hv.29609.
Mucosal immunization in perspective.
Rose MA.
Author information
Abstract

Pandemic and seasonal influenza viruses are a constant public health threat with substantial morbidity and mortality worldwide. Prophylaxis is hard to realize, but immunization provides an efficient tool to control the disease. Despite most infections occurring at or through mucosal surfaces, vaccines are predominantly administered parenterally. Recently it has been suggested that vaccines applied via mucosal surfaces may be a viable novel approach. A number of clinical studies have proven live attenuated influenza vaccine given intranasally to have equivalent or superior immunogenicity and efficacy at the upper and lower respiratory tract compared with systemic intramuscular vaccination. Intranasal application provides easy administration facilitating mass immunization campaigns which requires no strictly sterile injection and is painless to recipients.
KEYWORDS:

diarrhea; gastroenteritis; mucosal; pediatric immunization; rota-virus

PMID:
25424827
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25424827
 
Back
Top Bottom